Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 63 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-swab test Clear all

Conditions: Bacterial Vaginosis
Interventions: 750 mg metronidazole/ 200 mg miconazole vaginal suppository, Standard of care; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Acute Respiratory Tract Infection
Interventions: Self-swab test; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 850 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: SARS-CoV-2 Infection, COVID-19
Interventions: iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test; Device · Diagnostic Test
Lead sponsor: New Day Diagnostics; Network
Eligibility: 2 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Anaheim, California • Knoxville, Tennessee

Conditions: Children With Medical Complexity (CMC), COVID-19
Interventions: BinaxNOW Rapid Antigen System; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Convulsion, Non-Epileptic
Interventions: Auricular acupuncture; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Chlamydial Infection, Gonorrhoea, Trichomoniasis
Interventions: Click Device; Device
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 14 Years to 99 Years · Female only
Enrollment: 295 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 8
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 5 more

Conditions: COVID 19
Interventions: COVID-19 PCR and serology testing; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Covid19
Interventions: BIOZEK COVID-19 Antigen Rapid Test; Diagnostic Test
Lead sponsor: Mach-E B.V.; Industry
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Flushing, New York

Conditions: Sexually Transmitted Infections, Gay, Pre Exposure Prophylaxis
Interventions: Quantitative survey, HIV and STI testing, Qualitative Assessment; Behavioral · Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 675 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: San Diego, California • Atlanta, Georgia • Chicago, Illinois

Conditions: SARS-CoV2 Infection, COVID-19
Interventions: iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test; Device
Lead sponsor: MP Biomedicals, LLC; Industry
Eligibility: 2 Years and older
Enrollment: 332 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: DeLand, Florida • Gainesville, Florida • St. Petersburg, Florida + 1 more

Conditions: Human Papillomavirus, Human Immunodeficiency Virus, Hepatitis C, ColoRectal Cancer
Interventions: OraQuick Swab, Fecal Immunochemical Test, OraQuick Fingerstick, Standard Screening Tests, HPV Self-Sampling Test, Home Based Screening Tests; Device · Other
Lead sponsor: University of Miami; Other
Eligibility: 50 Years to 64 Years
Enrollment: 754 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: COVID-19, Children With Medical Complexity (CMC)
Interventions: BinaxNOW Rapid Antigen System; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy Subjects, HPV
Interventions: BD Cor OnClarity Self-Collection, BD Onclarity HPV Assay; Device · Diagnostic Test
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: COVID-19, Influenza A, Influenza B
Interventions: MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o); Diagnostic Test
Lead sponsor: Medical Group Care, LLC; Industry
Eligibility: 2 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Human Papillomavirus
Interventions: Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test"); Diagnostic Test
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cancer
Interventions: Avantect Multi-Cancer Detection Test, Nasal Swab; Device · Diagnostic Test
Lead sponsor: Inova Health Care Services; Other
Eligibility: 35 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Sexually Transmitted Disease (STD), Gonorrhea, Chlamydia, Trichomonas Infection
Interventions: Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas; Diagnostic Test
Lead sponsor: Queen's Medical Center; Other
Eligibility: 14 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Cervical Cancers, HPV
Interventions: HPV testing; Diagnostic Test
Lead sponsor: University of Rochester; Other
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: COVID-19, Influenza A, Influenza Type B
Interventions: Panbio™; Diagnostic Test
Lead sponsor: Abbott Rapid Dx; Industry
Eligibility: Not listed
Enrollment: 903 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Easley, South Carolina

Conditions: Melanoma, Skin Cancer
Interventions: Questionnaire; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 4,082 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19 Respiratory Infection, Influenza A, Influenza Type B, RSV Infection
Interventions: Labcorp COVID-19+Flu+RSV Test Home Collection Kit; Device
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 2 Years to 89 Years
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Pasadena, California

Conditions: COVID-19, Influenza
Interventions: Lucira COVID-19 & Flu Test; Device
Lead sponsor: Lucira Health Inc; Industry
Eligibility: 2 Years and older
Enrollment: 1,361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 7
States / cities: Cullman, Alabama • Colton, California • Oakland, California + 4 more

Conditions: Contraception
Interventions: Subcutaneous depot medroxyprogesterone acetate; Drug
Lead sponsor: Planned Parenthood Federation of America; Other
Eligibility: 15 Years to 44 Years · Female only
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Morristown, New Jersey • Houston, Texas

Conditions: Papillomavirus Infections
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis

HAIQU (Hospital AIr QUality)

COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation

ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff

Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures

Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs

MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.

HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance

BD Onclarity HPV Assay on the BD COR Instrument: Self-collected Vaginal Swabs Validation

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

Advancing Cervical Cancer Screening Through the Emergency Department - IIS

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

A Model for Genetic Susceptibility: Melanoma

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Performance Evaluation of the Lucira COVID-19 & Flu Test

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

Self-collected Swabs for HPV Testing in 18-24 Year Old Women